August 9, 2025

Port Delivery System Sustains nAMD Control Over 5 Years

Five-year data from the Portal extension study show durable outcomes with reduced treatment burden for Genentech’s Susvimo.

By Jim Gallagher, senior managing editor

August 9, 2025

OTX-TKI May Decrease Retinal Leakage in NPDR

A post hoc analysis of imaging from the HELIOS trial suggests a durable effect from the intraocular implant.

By Jim Gallagher, senior managing editor

August 9, 2025

Video: Fellow Eye Data Supports GA Clinical Trial Design

At ASRS, Diana Do, MD, presented results of a post hoc analysis of the OAKS and DERBY trials of geographic atrophy growth rates in untreated eyes vs sham eyes.

By Diana V. Do, MD, Roger A. Goldberg, MD, MBA

August 4, 2025

Video: Can Vonaprument Slow Vision Loss in GA?

David Eichenbaum, MD, and Diana Do, MD, discuss the rationale for and progress of the fully enrolled ARCHER II trial at ASRS 2025.

By David A. Eichenbaum, MD, Diana V. Do, MD

August 3, 2025

Video: Long-Term GA Data Support Early Treatment

At ASRS 2025, Roger Goldberg, MD, presented 48-month results from OAKS, DERBY, and GALE. He discussed the findings with Diana Do, MD.

By Roger A. Goldberg, MD, MBA, Diana V. Do, MD

August 2, 2025

Aflibercept 8 mg Meets Primary Endpoint in QUASAR

Week 36 data reported at ASRS show sustained visual and anatomic improvement with fewer injections.

By Jim Gallagher, senior managing editor

August 2, 2025

New AI Model Predicts Course of Geographic Atrophy

A better understanding of GA lesion growth patterns could refine trial design and therapeutic decisions for late-stage dry AMD.

By Jim Gallagher, senior managing editor

August 2, 2025

Video: Getting Gas Tamponade Right

Gaurav Shah, MD, joins Diana Do, MD, to discuss how errors in intraocular gas concentration can lead to preventable blindness, and what surgeons can do to avoid vision-threatening mistakes.

By Gaurav K. Shah, MD, Diana V. Do, MD

August 2, 2025

Video: Study Confirms AI Accuracy in Home OCT Monitoring

Krishna Mukkamala, MD, presented a longitudinal analysis at ASRS showing that the home OCT algorithm closely matched expert grader assessments in near-daily scans of patients with neovascular AMD.

August 2, 2025

Higher-Volume Injections Don’t Elevate Glaucoma Risk

An analysis of real-world data finds no significant pressure increases or glaucoma risk with higher-volume agents aflibercept 8 mg, pegcetacoplan, or avacincaptad pegol.

By Jim Gallagher, senior managing editor

August 2, 2025

Complement Inhibition Slows GA in Eyes With Wet AMD

A retrospective analysis presented at ASRS 2025 shows a sharply reduced lesion growth rate and stable CNV activity in treated eyes.

By Jim Gallagher, senior managing editor

August 2, 2025

Video: Can a Glaucoma Drug Prevent Retinal Scarring?

Leo A. Kim, MD, PhD, shares early research with Diana Do, MD, on netarsudil’s emerging role in managing proliferative vitreoretinopathy.

By Leo A. Kim, MD, PhD, Diana V. Do, MD

August 1, 2025

Video: Faricimab Maintains Long-Term Stability in DME

Four-year data from the RHONE-X study, presented at ASRS, show sustained BCVA, CST improvements, and extended dosing potential in patients with diabetic macular edema.

By Veeral S. Sheth, MD, MBA, FACS

August 1, 2025

Video: Durable Results with Gore-Tex Sutures

Luis Acabá-Berrocal, MD, shares 8-year outcomes of Gore-Tex–sutured IOLs in complex eyes.

By Luis A. Acabá-Berrocal, MD

August 1, 2025

Study Finds Retinal Detachment Risk Elevated in ROP Adults

In adult patients with a history of retinopathy of prematurity, rates of retinal tear or detachment after cataract surgery far exceed those in the general population.

By Jim Gallagher, senior managing editor

August 1, 2025

Oral Gildeuretinol Slows Stargardt Progression

Interim data from TEASE‑3 presented at ASRS show stabilization of vision and retinal structure in patients with early-stage disease.

By Jim Gallagher, senior managing editor

August 1, 2025

Video: Dual-Action Gene Therapy for DME Shows Safety and Durability

David Almeida, MD, presented interim data from the SPECTRA trial of 4D-150 gene therapy in adults with diabetic macular edema

By DAVID R.P. ALMEIDA, MD, MBA, PHD

August 1, 2025

Video: Reducing Injections in Wet AMD

Avni Finn, MD, and Diana Do, MD, discuss promising results from the DAVIO2 trial of EYP-1901.

By Avni Finn, MD, MBA, Diana V. Do, MD

August 1, 2025

Video: Should Fellow-Eye Lattice Prompt Early Laser?

Chase Ludwig, MD, joins Diana V. Do, MD, to review real-world data suggesting that prompt laser in lattice eyes may reduce future retinal detachments.

By Chase Ludwig, MD, Diana V. Do, MD

July 31, 2025

Artificial Intelligence vs Lincoff for Retinal Detachment Diagnostics

What can AI learn from 1,000 retinal detachment cases? More than you’d think.

By Jim Gallagher, senior managing editor

July 31, 2025

Video: No Evidence That AREDS Vitamins Slow GA Progression

A post hoc analysis of OAKS and DERBY data failed to support the foveal protection suggested by an earlier AREDS study.

By Paul Hahn, MD, PhD

July 31, 2025

Incoming ASRS President Shares Vision for Future

Geoffrey G. Emerson, MD, PhD, talks about inclusion, innovation, and why early career engagement is key to the Society’s continuing development.

By Jim Gallagher, senior managing editor

July 31, 2025

LIGHTSITE IIIB Extends PBM Evidence in Dry AMD

Findings from the multisite trial of photobiomodulation suggest visual gains can persist after reinitiation of therapy.

By Jim Gallagher, senior managing editor

July 31, 2025

Video: Tips for Treating Traction Retinal Detachments

Maria Berrocal, MD, shares her approach to these challenging cases with Diana Do, MD. The first day of the 2025 ASRS meeting focused on surgical technique and innovation.

July 31, 2025

Video: Surgical Retina Takes Center Stage at ASRS 2025

Gaurav Shah, MD, who planned the program for the annual meeting, explains why the first day was all about surgery.